Daniel Dix

921 total citations · 1 hit paper
17 papers, 603 citations indexed

About

Daniel Dix is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Daniel Dix has authored 17 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Daniel Dix's work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Genetic factors in colorectal cancer (3 papers). Daniel Dix is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Genetic factors in colorectal cancer (3 papers). Daniel Dix collaborates with scholars based in United States, Spain and Canada. Daniel Dix's co-authors include Richard B. Lanman, Davey B. Daniel, Karen L. Reckamp, Justin I. Odegaard, Stephen G. Divers, Ray D. Page, Victoria M. Raymond, Miguel A. Villalona‐Calero, Natasha B. Leighl and Vassiliki A. Papadimitrakopoulou and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Daniel Dix

17 papers receiving 590 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer

2019 408 citations Natasha B. Leighl, Ray D. Page et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Dix United States	8	408	381	186	167	109	17	603
Yao-Lung Kuo Taiwan	15	360 0.9×	92 0.2×	175 0.9×	191 1.1×	188 1.7×	32	692
Derrick S. Haslem United States	9	175 0.4×	154 0.4×	208 1.1×	54 0.3×	68 0.6×	30	459
Nawfel Mellas Morocco	11	119 0.3×	144 0.4×	296 1.6×	82 0.5×	76 0.7×	91	525
JN Atkins United States	11	143 0.4×	200 0.5×	303 1.6×	117 0.7×	34 0.3×	22	500
Maria Margarete Karsten Germany	14	204 0.5×	70 0.2×	189 1.0×	107 0.6×	81 0.7×	44	449
Alexandre Buckley de Meritens United States	9	86 0.2×	151 0.4×	221 1.2×	98 0.6×	44 0.4×	37	512
Sweety Gupta India	11	238 0.6×	101 0.3×	100 0.5×	245 1.5×	27 0.2×	90	559
David J. Einstein United States	13	125 0.3×	258 0.7×	226 1.2×	133 0.8×	17 0.2×	71	544
Kate Ingarfield United Kingdom	9	95 0.2×	152 0.4×	197 1.1×	133 0.8×	30 0.3×	17	550

Countries citing papers authored by Daniel Dix

Since Specialization

Citations

This map shows the geographic impact of Daniel Dix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dix more than expected).

Fields of papers citing papers by Daniel Dix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Dix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dix. The network helps show where Daniel Dix may publish in the future.

Co-authorship network of co-authors of Daniel Dix

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Dix. A scholar is included among the top collaborators of Daniel Dix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Dix. Daniel Dix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Page, Ray D., Leylah Drusbosky, Victoria M. Raymond, et al.. (2021). Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer. Clinical Lung Cancer. 23(1). 72–81. 31 indexed citations

Palmero, Ramón, Álvaro Taus, Santiago Viteri, et al.. (2021). Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 5(5). 93–102. 38 indexed citations

Leighl, Natasha B., Ray D. Page, Victoria M. Raymond, et al.. (2019). Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer. Clinical Cancer Research. 25(15). 4691–4700. 408 indexed citations breakdown →

Leighl, Natasha B., Ray D. Page, Victoria M. Raymond, et al.. (2019). Abstract 4460: Clinical utility of comprehensive cell-free DNA (cfDNA) analysis to identify genomic biomarkers in newly diagnosed metastatic non-small cell lung cancer (mNSCLC). 4460–4460. 3 indexed citations

Esquivel, Mikaela, Li Zhang, Carlos U. Corvera, et al.. (2019). Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation: Interim results.. Journal of Clinical Oncology. 37(4_suppl). 552–552. 1 indexed citations

Bracht, Jillian Wilhelmina Paulina, Niki Karachaliou, Richard B. Lanman, et al.. (2019). Tracking plasma KRAS mutations (mu) in lung adenocarcinoma (LUAC) patients (p) and branching evolution.. Journal of Clinical Oncology. 37(15_suppl). 9055–9055. 1 indexed citations

Dix, Daniel, et al.. (2018). Correlation of Appointment Times and Subspecialty With the No-Show Rates in an Orthopedic Ambulatory Clinic. Journal of Healthcare Management. 63(6). e159–e169. 13 indexed citations

Dix, Daniel, Andrew M. McDonald, Jennifer Gordetsky, et al.. (2018). How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?. Urology. 122. 139–146. 5 indexed citations

Dix, Daniel, et al.. (2018). Comparative Analysis of Short-Term Postoperative Complications in Outpatient Versus Inpatient Total Ankle Arthroplasty: A Database Study. The Journal of Foot & Ankle Surgery. 58(1). 23–26. 20 indexed citations

10.

Karachaliou, Niki, Martina I. Lefterova, Imane Chaib, et al.. (2018). Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA). Annals of Oncology. 29. viii671–viii671. 1 indexed citations

11.

Dix, Daniel, et al.. (2018). A systematic review and meta-analysis of complications in conversion arthroplasty methods for failed intertrochanteric fracture fixation. Journal of Clinical Orthopaedics and Trauma. 10(2). 282–285. 6 indexed citations

12.

Palmero, Ramón, Álvaro Taus, Santiago Viteri, et al.. (2018). P2.03-02 Cell-Free DNA (cfDNA) Testing in Lung Adenocarcinoma (LUAC) Patients: Spanish Lung Liquid Versus Invasive Biopsy Program (SLLIP). Journal of Thoracic Oncology. 13(10). S716–S717. 2 indexed citations

13.

Bernards, Daniel A., Hunter H. Chen, Jingtai Cao, et al.. (2018). Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery. Bioengineering & Translational Medicine. 4(1). 152–163. 11 indexed citations

14.

Crotts, George, Christine Wurth, Valentyn Antochshuk, et al.. (2017). An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies. Journal of Pharmaceutical Sciences. 107(2). 529–542. 4 indexed citations

15.

Foley, Perry, Erica Levine, Sandy Askew, et al.. (2012). Weight gain prevention among black women in the rural community health center setting: The Shape Program. BMC Public Health. 12(1). 305–305. 41 indexed citations

16.

Cao, J., Hang Song, Daniel Dix, et al.. (2007). Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap. Investigative Ophthalmology & Visual Science. 48(13). 1710–1710. 1 indexed citations

17.

Arakawa, Tsutomu, Daniel Dix, & Byeong S. Chang. (2003). The Effects of Protein Stabilizers on Aggregation Induced by Multiple-Stresses. YAKUGAKU ZASSHI. 123(11). 957–961. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact